Back to Search
Start Over
Golcadomide Exhibits Durable CMR Rates in B-Cell Lymphoma.
- Source :
- Targeted Therapies in Oncology; Oct2024, Vol. 13 Issue 13, p15-17, 3p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15398226
- Volume :
- 13
- Issue :
- 13
- Database :
- Complementary Index
- Journal :
- Targeted Therapies in Oncology
- Publication Type :
- Periodical
- Accession number :
- 180289970